UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited

The Lancet (British edition), 2009-01, Vol.373 (9658), p.155-166

2009

Volltextzugriff (PDF)

Clinical Features Associated with ‘Normal Range’ Fibrin D-Dimer Levels in Atrial Fibrillation Patients with Left Atrial Thrombus

Clinical and applied thrombosis/hemostasis, 2022-01, Vol.28, p.10760296221133380-10760296221133380

2022

Volltextzugriff (PDF)

Socioeconomic inequality in oral anticoagulation therapy initiation in patients with atrial fibrillation with high risk of stroke: a register-based observational study

BMJ open, 2021-05, Vol.11 (5), p.e048839-e048839

2021

Volltextzugriff (PDF)

Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial

The Lancet (British edition), 2007-08, Vol.370 (9586), p.493-503

2007

Volltextzugriff (PDF)

Silent Cerebral Infarction in East Asian vs. Non-Asian Atrial Fibrillation Patients　― Meta-Analysis

Circulation Journal, 2018/02/23, Vol.82(3), pp.672-676

2018

Volltextzugriff (PDF)

Atrial fibrillation in acute heart failure: A position statement from the Acute Cardiovascular Care Association and European Heart Rhythm Association of the European Society of Cardiology

European heart journal. Acute cardiovascular care, 2020-06, Vol.9 (4), p.348-357

2020

Volltextzugriff (PDF)

Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial

Lancet neurology, 2012-03, Vol.11 (3), p.225-231

2012

Volltextzugriff (PDF)

Management of atrial fibrillation

The Lancet (British edition), 2007-08, Vol.370 (9587), p.604-618

2007

Volltextzugriff (PDF)

Atrial fibrillation and stroke prevention

Lancet neurology, 2007-11, Vol.6 (11), p.981-993

2007

Volltextzugriff (PDF)

Non-Vitamin K Antagonist oral Anticoagulants : a Concise Guide

1, 2016

Volltextzugriff (PDF)

Temporal Trends in Stroke Severity and Prior Antithrombotic Use Among Acute Ischemic Stroke Patients in Japan

Circulation Journal, 2016/08/25, Vol.80(9), pp.2033-2036

2016

Volltextzugriff (PDF)

Enrollment of Black, Indigenous and People of Color (BIPOC) and female participants in the US diabetes trials spanning 2000 to 2020: A chronological survey

Diabetes & metabolic syndrome clinical research & reviews, 2024-07, Vol.18 (7), p.103074, Article 103074

2024

Volltextzugriff (PDF)

10-year nationwide trends of the incidence, prevalence, and adverse outcomes of non-valvular atrial fibrillation nationwide health insurance data covering the entire Korean population

The American heart journal, 2018-08, Vol.202, p.20-26

2018

Volltextzugriff (PDF)

Neurovascular coupling and cerebral autoregulation in atrial fibrillation

Journal of cerebral blood flow and metabolism, 2020-08, Vol.40 (8), p.1647-1657

2020

Volltextzugriff (PDF)

Men who live alone have worse anticoagulation control: A Danish registry study

The American heart journal, 2023-03, Vol.257, p.30-32

2023

Volltextzugriff (PDF)

Association between clinical risk scores and mortality in atrial fibrillation: Systematic review and network meta-regression of 669,000 patients

European journal of preventive cardiology, 2020-04, Vol.27 (6), p.633-644

2020

Volltextzugriff (PDF)

Modern Management of Atrial Fibrillation Requires Initial Identification of “Low-Risk” Patients Using the CHA2DS2-VASc Score, and Not Focusing on “High-Risk” Prediction

Circulation Journal, 2014, Vol.78(8), pp.1843-1845

2014

Volltextzugriff (PDF)

Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death: Position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE

European journal of preventive cardiology, 2017-01, Vol.24 (1), p.41-69

2017

Volltextzugriff (PDF)

Sex-Related Differences in the Clinical Events of Patients With Atrial Fibrillation　― The Fushimi AF Registry

Circulation Journal, 2017/09/25, Vol.81(10), pp.1403-1410

2017

Volltextzugriff (PDF)

The 2020 ESC Guidelines on the Diagnosis and Management of Atrial Fibrillation

Arrhythmia & electrophysiology review, 2021-07, Vol.10 (2), p.65-67

2021

Volltextzugriff (PDF)

Association between metabolically healthy obesity and risk of atrial fibrillation: taking physical activity into consideration

Cardiovascular diabetology, 2022-10, Vol.21 (1), p.208-208, Article 208

2022

Volltextzugriff (PDF)

Pharmacological modulation of microparticle release: new strategies for the management of atherothrombotic vascular disorders

Current pharmaceutical design, 2012-02, Vol.18 (6), p.840-849

2012

Volltextzugriff (PDF)

Bare-Metal vs. Drug-Eluting Stents in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: Insights From the AFCAS Registry

Circulation Journal, 2014/10/24, Vol.78(11), pp.2674-2681

2014

Volltextzugriff (PDF)

Time in therapeutic range and major adverse outcomes in atrial fibrillation patients undergoing percutaneous coronary intervention: The Atrial Fibrillation Undergoing Coronary Artery Stenting (AFCAS) registry

The American heart journal, 2017-08, Vol.190, p.86-93

2017

Volltextzugriff (PDF)

Catheter Ablation of Atrial Fibrillation and Thromboembolic Risk

Circulation Journal, 2015/01/23, Vol.79(2), pp.444

2015

Volltextzugriff (PDF)

1 – 25 von 771

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(741)
Mit Volltextzugriff
(648)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(536)
Life Sciences & Biomedicine
(533)
Humans
(461)
Cardiovascular System & Cardiology
(297)
Stroke
(241)
Cardiac & Cardiovascular Systems
(230)
Female
(225)
Male
(217)
Atrial Fibrillation
(209)
Cardiac Arrhythmia
(206)
Risk Factors
(186)
Aged
(183)
Anticoagulants
(161)
Middle Aged
(147)
Atrial Fibrillation - Complications
(136)
Atrial Fibrillation - Drug Therapy
(124)
Cardiology
(124)
General & Internal Medicine
(123)
Medicine, General & Internal
(118)
Stroke - Prevention & Control
(110)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited

Clinical Features Associated with ‘Normal Range’ Fibrin D-Dimer Levels in Atrial Fibrillation Patients with Left Atrial Thrombus

Socioeconomic inequality in oral anticoagulation therapy initiation in patients with atrial fibrillation with high risk of stroke: a register-based observational study

Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial

Silent Cerebral Infarction in East Asian vs. Non-Asian Atrial Fibrillation Patients　― Meta-Analysis

Atrial fibrillation in acute heart failure: A position statement from the Acute Cardiovascular Care Association and European Heart Rhythm Association of the European Society of Cardiology

Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial

Management of atrial fibrillation

Atrial fibrillation and stroke prevention

Non-Vitamin K Antagonist oral Anticoagulants : a Concise Guide

Temporal Trends in Stroke Severity and Prior Antithrombotic Use Among Acute Ischemic Stroke Patients in Japan

Enrollment of Black, Indigenous and People of Color (BIPOC) and female participants in the US diabetes trials spanning 2000 to 2020: A chronological survey

10-year nationwide trends of the incidence, prevalence, and adverse outcomes of non-valvular atrial fibrillation nationwide health insurance data covering the entire Korean population

Neurovascular coupling and cerebral autoregulation in atrial fibrillation

Men who live alone have worse anticoagulation control: A Danish registry study

Association between clinical risk scores and mortality in atrial fibrillation: Systematic review and network meta-regression of 669,000 patients

Modern Management of Atrial Fibrillation Requires Initial Identification of “Low-Risk” Patients Using the CHA2DS2-VASc Score, and Not Focusing on “High-Risk” Prediction

Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death: Position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE

Sex-Related Differences in the Clinical Events of Patients With Atrial Fibrillation　― The Fushimi AF Registry

The 2020 ESC Guidelines on the Diagnosis and Management of Atrial Fibrillation

Association between metabolically healthy obesity and risk of atrial fibrillation: taking physical activity into consideration

Pharmacological modulation of microparticle release: new strategies for the management of atherothrombotic vascular disorders

Bare-Metal vs. Drug-Eluting Stents in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: Insights From the AFCAS Registry

Time in therapeutic range and major adverse outcomes in atrial fibrillation patients undergoing percutaneous coronary intervention: The Atrial Fibrillation Undergoing Coronary Artery Stenting (AFCAS) registry

Catheter Ablation of Atrial Fibrillation and Thromboembolic Risk

Suchergebnisse filtern